Recently, ApTOLL—a single-stranded DNA aptamer—and alpha-keto acids generated by the amino acid oxidase interleukin-4 induced 1 (IL4I1) have been reported as new drug candidates for MS (Fernández-Gómez et al., 2024; Hu et al., 2024). This evidence concerns the gene IL4I1 and myeloid sarcoma.